Skip to main content
Clinical Trials/NL-OMON26542
NL-OMON26542
Recruiting
Not Applicable

A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study

Erasmus MC0 sites360 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oesophageal cancer, oesofaguscarcinoom, esophageal cancer, active surveillance
Sponsor
Erasmus MC
Enrollment
360
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • Operable patients who are planned to undergo or who recently underwent neoadjuvant chemoradiotherapy according to CROSS followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of the oesophagus or oesophago\-gastric junction
  • \- Age \=18
  • \- Written, voluntary, informed consent.

Exclusion Criteria

  • \- Non\-FDG\-avid tumour at baseline PET\-CT scan
  • \- Initial treatment with endoscopic resection
  • \- Patients who underwent of who are planned to undergo definitive chemoradiotherapy
  • \- Language difficulty, dementia or altered mental status prohibiting the understanding and giving of informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials